Other
Surgery
4
Pipeline Programs↗
39
Active Trials↗
16
Companies Involved↗
Surgery is an early-stage landscape with 4 programs across 16 companies. The most active players are Exela Pharma Sciences, LLC., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Sun Pharma. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
233
clinical trials
Completed130 · 56%
Unknown status28 · 12%
Terminated22 · 9%
Recruiting20 · 9%
Withdrawn14 · 6%
Not yet recruiting10 · 4%
Other9 · 4%
Clinical Trials
Trial Activity
233 trials
Zinc Oxide Versus Petrolatum Following Skin Surgery
Recruiting·—·Phase 1·NCT03561376·30 enrolled
Nalbuphine in ARDS Patients After Surgery
Recruiting·—·Phase 4·NCT06037330·60 enrolled
Page 1 of 16
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)